Angion Biomedica (NASDAQ:ANGN – Free Report) and Opthea (NASDAQ:OPT – Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Profitability This table compares Angion Biomedica and Opthea’s net margins, […]
Angion Biomedica Corp. (NASDAQ:ANGN – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 64,600 shares, a growth of 17.7% from the April 15th total of 54,900 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average […]
Angion Biomedica Corp. (NASDAQ:ANGN – Get Rating) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 71,900 shares, a drop of 18.9% from the February 28th total of 88,700 shares. Based on an average daily volume of 66,300 shares, the […]
Angion Biomedica (NASDAQ:ANGN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Angion Biomedica Corp. is a late-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel […]